Drug profile · INN
tafluprost
ZIOPTAN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tafluprost (ZIOPTAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN tafluprost
Brand ZIOPTAN
Route OPHTHALMIC
Formulation SOLUTION/DROPS
Frequently asked questions
What is tafluprost?
tafluprost (ZIOPTAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for tafluprost?
ZIOPTAN is a marketed brand name for tafluprost. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tafluprost?
tafluprost has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.